1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA00506070
okratod dose yet determined Well characterized mechanism of action • Selective viral DNA-polymerase inhibitor • Up to 400-times more potent than Acydovir with better Intracellular concentrations and half-lives 5 EFTA00506074 2013-08-22 Strong in vitro & preclinical data provide consistent rational
No connected entities